#cardiovascular

HIV-positive individuals tend to develop frailty at a younger age than the general population.

Researchers analyzed health data from 2004 and 2014 regarding a cohort of people with HIV who initially had a median age of 41.

More research is needed to determine the potential risks and benefits of testosterone treatment in this population.

Statins are currently under investigation as a preventive for inflammation-related health problems in people with HIV.

That’s according to an analysis of HIV-positive people released from jail or prison in Connecticut.

A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.

Living with chronic pain not only drags down quality of life, but it is also linked to poorer HIV-related health outcomes.

A new analysis of a massive amount of global data reached a conclusion similar to that of previous research.

This increased risk is not driven by differences in plaque buildup in the arteries compared with those who are HIV negative.

This connection remained even when researchers took into account various risk factors for cardiovascular disease.

A recent meta-analysis compared side effects linked to Tivicay versus other antiretrovirals.

A recent study found that factors other than coronary plaque likely drive this sex-based difference.

Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.

A recent study found that the virus was associated with abdominal obesity as well as high triglycerides and low LDL cholesterol.

Aside from taking antiretrovirals, quitting smoking is the number one way people with HIV can lower their risk of illness and death.

The Campbell Foundation awards $100,000 to The Wistar Institute to explore glycobiology and HIV.